
Sign up to save your podcasts
Or


Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?
By ReachMD3.9
88 ratings
Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?

8,043 Listeners

29,272 Listeners